Ureteroscope Market Regional Analysis

North America is expected to rule the global ureteroscope market due to favorable reimbursement policies, state-of-the-art healthcare infrastructure, and well-established guidelines for the surgical and medical management of upper tract stone disease, all of which are expected to drive the market for ureteroscopes.

Furthermore, the increased use of ureteroscopes in the United States is a result of the rising numbers of instances of upper tract urothelial carcinoma (UTUC). For example, according to data from the Centers for Disease Control and Prevention (CDC)2020, the US has about 17,500 women and 56,000 men who have bladder cancer. Additionally, the Canadian Cancer Society estimates that 12,200 Canadians will be diagnosed with bladder cancer in the year 2020.

Launch of newer products to drive the market further. For example, AXIS single use digital flexible ureteroscope was launched by Dornier Medtech in 2019. High ureteroscopy success rates to increase the growth of the ureteroscope market. For instance, data from the Department of Urology at New York Medical College from 2016 show that after just one surgery, almost 37% of patients who underwent flexible ureteroscopy were stone-free, compared to only 21% of patients who underwent extracorporeal shock wave lithotripsy (ESWL). Moreover, the two biggest American competitors in this market are Boston Scientific Corporation and Stryker Corporation. Additionally, it is anticipated that the rising incidence of kidney stones in the U.S. will boost demand for ureteroscopes, which in turn will fuel market expansion in North America. For instance, according to data from the National Center for Biotechnology Information, in 2021, there was a rapid rise in the prevalence of urinary tract stone disease. Around 10.6% of men and 7.1 percent of women in the U.S. are affected by renal stone disease.

Due to the rising prevalence of kidney stone illness in India and China, the Asia Pacific region is predicted to have considerable growth in the worldwide ureteroscopes market. For instance, the prevalence of kidney stones in Mainland China was estimated to be approximately 10.34 percent in men and 6.62 percent in women, according to statistics published in the National Center for Biotechnology Information in 2020.

Ureteroscope market is firmly established in Europe. Despite the Covid-19 pandemic hindering market expansion, this region will have a large increase as long as the businesses keep supplying cutting-edge modifications. The key competitors within Europe's ureteroscope market are Coloplast and Wellspect Healthcare alongside other market leaders such as Becton Dickinson, Hollister Inc. and Boston Scientific.